in Blog post

Breast cancer risk cut by 35% in new clinical trial

1.5k Views

Breast cancer risk cut by 35% in new clinical trial

Trodelvy, in combination with Merck’s immunotherapy Keytruda, lowered the risk of an aggressive type of breast cancer worsening by 35% when used as an initial treatment, according to new results…
Read More

What do you think?

0 Points
Upvote Downvote

Written by Shane

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Loading…

0
The four potential sellers that could shake up MLB’s looming trade deadline

The four potential sellers that could shake up MLB’s looming trade deadline
How Many Episodes Are There of ‘MobLand’?

How Many Episodes Are There of ‘MobLand’?